Aclaris Therapeutics (ACRS) Other financing activities (2016 - 2026)
Aclaris Therapeutics (ACRS) posted quarterly Other financing activities of $151000.0 for Q1 2026, up 208.16% quarter-over-quarter from $49000.0 in Q4 2023.
Aclaris Therapeutics (ACRS) Other financing activities (2016 - 2026) Analysis & Trends
Aclaris Therapeutics' Other financing activities history runs 9 years deep, the most recent figure standing at $151000.0 for Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $151000.0; the TTM figure through Mar 2026 stood at $215000.0 (changed N/A YoY), while the FY2024 annual figure was $32000.0, down 65.96% from the prior year.
- Other financing activities for Q1 2026 stood at $151000.0, up from $49000.0 in the prior quarter.
- The five-year high for Other financing activities was $151000.0 in Q1 2026, with the low at $15000.0 in Q3 2023.
- The 3-year median for Other financing activities is $43000.0 (2022), against an average of $62000.0.
- The sharpest annual moves came in 2022 and 2023: Other financing activities tumbled 92.04% in 2022, then jumped 32.43% in 2023.
- Aclaris Therapeutics' Other financing activities stood at $37000.0 in 2022, then surged by 32.43% to $49000.0 in 2023, then soared by 208.16% to $151000.0 in 2026.
- Business Quant data shows ACRS's Other financing activities at $151000.0 in Q1 2026, $49000.0 in Q4 2023, and $15000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Aclaris Therapeutics | 808.18 Mn | 716.63 Mn | 1.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 114,000.00 |
| Jun 30, 2026 | 114,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Jun 30, 2022 | 83,000.00 |
| Jun 30, 2022 | 83,000.00 |
| Mar 31, 2022 | 37,000.00 |
| Mar 31, 2022 | 37,000.00 |
| Jun 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | 1.04 Mn |
| Mar 31, 2021 | 416,000.00 |
| Mar 31, 2021 | 416,000.00 |
| Mar 31, 2020 | 25,000.00 |
| Mar 31, 2020 | 25,000.00 |